Urinalysis Market

Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland) and Cardinal Health, Inc. (US) are Leading players in Urinalysis Market

The global urinalysis market size is projected to reach USD  4.9 billion by 2026 from USD 3.5 billion in 2021, at a CAGR of 7.2% during the forecast period. Growth in the urinalysis industry is mainly driven by factors such as the increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests. On the other hand, availability of refurbished urine analyzers is expected to limit market growth to a certain extent in the coming years.

The major players in this market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (UK), Alphatech Scientific (Peru), Teco Diagnostics (US), Analyticon Technologies AG (Germany), Bioway Biological Technology Co. Ltd. (China), High Technology Inc. (US) and Agappe Diagnostics Ltd. (India).

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers AG accounted for the largest share of the urinalysis market in 2020. The company has a direct presence across the globe and is directly represented in more than 70 countries worldwide. The company adopted inorganic growth strategies to increase its market share. For instance, in 2018 it partnered with Healthy.io Ltd. to integrate its urinalysis reagents into the Healthy.io’s smartphone-based urinalysis system. The company intends to partner with new businesses to complement its existing business segments. Such developments enable the company to add innovative technologies and products to its portfolio, which, in turn, will strengthen its presence in the urinalysis market.

F. Hoffmann-La Roche Ltd. accounted for the second-largest share of the urinalysis market in 2020. Roche is a major player in the biochemical urinalysis market owing to its vast product portfolio of urine analyzers and test strips. The company focuses on innovation for maintaining its market share and significantly invests in R&D activities for this purpose. This investment is used for developing new and innovative products. The company’s position in this market can also be attributed to its strong sales and distribution network across the globe, which enables it to effectively market its products in various countries. It has a wide geographic presence across 180 countries throughout the Americas, Europe, Asia, and the Middle East & Africa. The company works in partnerships with third parties to offer integrated solutions.

Cardinal Health, Inc. accounted for the third-largest share of the urinalysis market. The company’s major share comes from the US markets. The company plans to expand its self-manufacturing capacity and sourcing capabilities while optimizing its end-to-end global supply chain. Acquiring other businesses that expands or complements the company’s existing businesses, is an important element of its growth strategy. The company implements cost savings initiatives, particularly within the global manufacturing and supply chain, which drives significant benefits throughout the year. The company is focused on growth to create long-term value which includes organic growth opportunities and strategic investments to diversify its capabilities.

Related Reports:

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Homecare) & Test Type - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 3259
RI Published ON
8/17/2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved